兰碳酸盐降低血清,而不会改变维持腹腔透析患者的体内负担:一个随机交叉试验
Joel D Kopple1, Rachelle Bross2, Maryam Ekramzadeh3
1Division of Nephrology, Hypertension and Transplantation, Harbor-UCLA Medical Center, Torrance, CA, United States; The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, United States; David Geffen School of Medicine at UCLA, Los Angeles, CA, United States; UCLA Fielding School of Public Health, Los Angeles, CA, United States.
兰碳酸盐有效降低了透析患者的血清. 然而,这种酸盐结合剂不会改变身体整体水平,尽管增加了便的分泌.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 临床药理学 临床药理学
- 矿物质的新陈代谢.
背景情况:
- 肠道酸盐结合剂被广泛用于治疗慢性病 (CKD) 患者的高酸血症.
- 关于这些结合剂对便酸盐分泌和身体整体负担的影响的研究有限.
研究的目的:
- 为了研究碳酸对便酸盐分泌的影响.
- 为了确定碳酸是否影响患有慢性功能衰竭的患者体内平衡,进行腹腔透析.
主要方法:
- 一项代谢平衡研究对七名接受维持腹腔透析的成年患者进行了研究.
- 患者接受了不同剂量的碳酸盐 (1.5,3.0和4.5g/d) 随机顺序在恒定的摄入量.
- 在整个研究期间,血清,透析液,尿液和便中的含量都被仔细测量.
主要成果:
- 增加剂量的碳酸显著降低了血清的度.
- 便的分泌逐渐增加与更高的碳酸盐剂量.
- 观察到透析剂和尿液的减少,与血清的减少相关,但净效应没有改变身体的平衡.
结论:
- 兰碳酸盐在腹腔透析的高血症患者中有效降低血清.
- 尽管便损失增加,但碳酸不会改变这些患者的全体含量.
更多相关视频
11:30A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
08:21Optimized Procedure for Determining the Adsorption of Phosphonates onto Granular Ferric Hydroxide using a Miniaturized Phosphorus Determination Method
Published on: May 18, 2018
相关概念视频
Peritoneal Dialysis III: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Introduction to Electrolytes
Role of Sodium
One...
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
